|
 |
| |
| |
|
| Cancer Prevention |
|
Introduction
Led by Caryn Lerman, Ph.D., the Institute's cancer prevention research program applies molecular genetics advances to the development of new cancer prevention and control strategies.
One area of research integrates patient decision-making with breast and colon cancer genetic testing for high-risk families. Lerman's team has recently found that the demand for genetic testing is significantly lower than anticipated, patients generally cope well with genetic test results, and significant adverse effects are rare. The group has also found that carriers of the breast and colon genes are not performing monitoring and prevention strategies at the recommended level.
Laboratories
Cancer Prevention is a core unit of the The Leonard and Madlyn Abramson Family Cancer Research Institute at the Abramson Cancer Center at the University of Pennsylvania. Created in December 1997 with a $100 million pledge from the Abramson Family Foundation, the Cancer Research Institute integrates research, education, and comprehensive patient care at the Abramson Cancer Center at the University of Pennsylvania. |
|
|
|
| |
| TOP |
|
|
| The University of Pennsylvania Health System © 2007, The Trustees of the University of Pennsylvania. Unauthorized reproduction of this material is strictly prohibited.
|
| Disclaimer | Contact Webmaster |
|
|
|
|
